-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on CG Oncology, Raises Price Target to $91

Benzinga·11/17/2026 13:20:19
Listen to the news
Wedbush analyst Robert Driscoll maintains CG Oncology (NASDAQ:CGON) with a Outperform and raises the price target from $84 to $91.